Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

Author： Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.39, Iss.6, 2009-06, pp. : 415-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes

By Yamamoto T.   Suzuki A.   Kohno Y.  

Xenobiotica, Vol. 33, Iss. 8, 2003-08 ,pp. : 823-839

Informa Healthcare

Access to resources Recommend Favorite

Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4

By Coller J. K.   Somogyi A. A.   Bochner F.  

Xenobiotica, Vol. 29, Iss. 10, 1999-10 ,pp. : 973-986

Informa Healthcare

Access to resources Recommend Favorite

Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes

By Miyazawa M.   Gyoubu K.  

Xenobiotica, Vol. 37, Iss. 2, 2007-02 ,pp. : 194-204

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes

By Hu Y.   Dehal S. S.   Hynd G.   Jones G. B.   Kupfer D.  

Xenobiotica, Vol. 33, Iss. 2, 2003-02 ,pp. : 141-151

Informa Healthcare

Access to resources Recommend Favorite

Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes

By Miyazawa M.   Gyoubu K.  

Xenobiotica, Vol. 37, Iss. 9, 2007-09 ,pp. : 943-953

Informa Healthcare

Access to resources Recommend Favorite